Johnson Financial Group Inc (Wisconsin)’s Maravai LifeSciences MRVI Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-970	Closed	-$6.35K	–	918
2023 Q4	$6.35K	Buy	+970	New	+$6.27K	﹤0.01%	703
2022 Q2	–	Sell	-4,000	Closed	-$141K	–	718
2022 Q1	$141K	Hold	4,000	–	–	0.01%	307
2021 Q4	$168K	Hold	4,000	–	–	0.01%	292
2021 Q3	$196K	Hold	4,000	–	–	0.01%	265
2021 Q2	$167K	Buy	4,000 +2,000	+100%	+$77.5K	0.01%	287
2021 Q1	$71K	Buy	+2,000	New	+$66.3K	﹤0.01%	367

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s MRVI Position: Q1 2024 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 970 shares — an estimated $6.35K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in MRVI in Q1 2021 and held it in 6 quarters. The position peaked at $196K in Q3 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

Johnson Financial Group Inc (Wisconsin) reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 970 Maravai LifeSciences shares in Q1 2024, an estimated $6.35K.
Johnson Financial Group Inc (Wisconsin) first reported a position in Maravai LifeSciences in Q1 2021 and held it in 6 quarters.
Johnson Financial Group Inc (Wisconsin)'s Maravai LifeSciences position peaked at $196K in Q3 2021.
210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2024, filed 14 May 2024.